| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake … JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ... Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015 | 1041 | 2015 |
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ... Clinical pharmacology and therapeutics 102 (1), 37, 2017 | 684 | 2017 |
| Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study SK Hill, JL Reilly, RSE Keefe, JM Gold, JR Bishop, ES Gershon, ... American Journal of Psychiatry 170 (11), 1275-1284, 2013 | 428 | 2013 |
| Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) CA Tamminga, EI Ivleva, MS Keshavan, GD Pearlson, BA Clementz, ... American Journal of psychiatry 170 (11), 1263-1274, 2013 | 387 | 2013 |
| Effect of second-generation antipsychotics on cognition: current issues and future challenges SK Hill, JR Bishop, D Palumbo, JA Sweeney Expert review of neurotherapeutics 10 (1), 43-57, 2010 | 321 | 2010 |
| Pharmacological treatment effects on eye movement control JL Reilly, R Lencer, JR Bishop, S Keedy, JA Sweeney Brain and cognition 68 (3), 415-435, 2008 | 273 | 2008 |
| Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss … DA Scott, R Wang, TM Kreman, M Andrews, JM McDonald, JR Bishop, ... Human Molecular Genetics 9 (11), 1709-1715, 2000 | 216 | 2000 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy JT Brown, JR Bishop, K Sangkuhl, EL Nurmi, DJ Mueller, JC Dinh, ... Clinical Pharmacology & Therapeutics 106 (1), 94-102, 2019 | 207 | 2019 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin … CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ... Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023 | 194 | 2023 |
| Review and consensus on pharmacogenomic testing in psychiatry CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ... Pharmacopsychiatry 54 (01), 5-17, 2021 | 172 | 2021 |
| A review of estrogen receptor α gene (ESR1) polymorphisms, mood, and cognition EE Sundermann, PM Maki, JR Bishop Menopause 17 (4), 874-886, 2010 | 164 | 2010 |
| Serotonin 2A− 1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects JR Bishop, J Moline, VL Ellingrod, SK Schultz, AH Clayton Neuropsychopharmacology 31 (10), 2281-2288, 2006 | 137 | 2006 |
| Association of choroid plexus enlargement with cognitive, inflammatory, and structural phenotypes across the psychosis spectrum P Lizano, O Lutz, G Ling, AM Lee, S Eum, JR Bishop, S Kelly, O Pasternak, ... American Journal of Psychiatry 176 (7), 564-572, 2019 | 133 | 2019 |
| Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers J G Fiedorowicz, D Del Miller, J R Bishop, C A Calarge, V L Ellingrod, ... Current psychiatry reviews 8 (1), 25-36, 2012 | 121 | 2012 |
| Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia C Chen, C Zhang, L Cheng, JL Reilly, JR Bishop, JA Sweeney, HY Chen, ... Bipolar disorders 16 (8), 790-799, 2014 | 117 | 2014 |
| Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options K Drozda, DJ Müller, JR Bishop Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (2 …, 2014 | 117 | 2014 |
| Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders LH Rubin, CS Carter, JR Bishop, H Pournajafi-Nazarloo, LL Drogos, ... Schizophrenia bulletin 40 (6), 1374-1384, 2014 | 111 | 2014 |
| Cognitive burden of anticholinergic medications in psychotic disorders S Eum, SK Hill, LH Rubin, RM Carnahan, JL Reilly, EI Ivleva, SK Keedy, ... Schizophrenia research 190, 129-135, 2017 | 102 | 2017 |
| Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. VL Ellingrod, JR Bishop, J Moline, YC Lin, DD Miller Psychopharmacology bulletin 40 (1), 57-62, 2007 | 101 | 2007 |
| Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment JR Bishop, VL Ellingrod, J Moline, D Miller Schizophrenia research 77 (2-3), 253-260, 2005 | 101 | 2005 |
